15.31
price up icon0.07%   0.010
 
loading
Schlusskurs vom Vortag:
$15.30
Offen:
$15.3
24-Stunden-Volumen:
150.26K
Relative Volume:
0.50
Marktkapitalisierung:
$366.87M
Einnahmen:
$47.26M
Nettoeinkommen (Verlust:
$-58.48M
KGV:
-7.2905
EPS:
-2.1
Netto-Cashflow:
$-40.45M
1W Leistung:
+13.24%
1M Leistung:
+52.04%
6M Leistung:
+105.50%
1J Leistung:
-24.02%
1-Tages-Spanne:
Value
$14.90
$15.67
1-Wochen-Bereich:
Value
$13.38
$16.02
52-Wochen-Spanne:
Value
$6.40
$33.13

Cvrx Inc Stock (CVRX) Company Profile

Name
Firmenname
Cvrx Inc
Name
Telefon
(763) 416-2850
Name
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Name
Mitarbeiter
200
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
CVRX's Discussions on Twitter

Vergleichen Sie CVRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
CVRX
Cvrx Inc
15.31 366.87M 47.26M -58.48M -40.45M -2.10
Medical Devices icon
ABT
Abbott Laboratories
118.95 208.18B 41.22B 5.77B 6.49B 2.94
Medical Devices icon
SYK
Stryker Corp
388.14 148.70B 21.97B 3.59B 3.21B 6.74
Medical Devices icon
BSX
Boston Scientific Corp
90.75 133.32B 15.91B 1.79B 1.89B 0.82
Medical Devices icon
MDT
Medtronic Plc
86.27 111.27B 33.00B 4.29B 5.50B 2.71
Medical Devices icon
EW
Edwards Lifesciences Corp
72.07 42.66B 6.60B 4.16B 490.10M 2.34

Cvrx Inc Stock (CVRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-10 Eingeleitet Cantor Fitzgerald Overweight
2024-07-11 Bestätigt Lake Street Buy
2024-05-01 Fortgesetzt Craig Hallum Buy
2024-05-01 Herabstufung JP Morgan Overweight → Neutral
2024-05-01 Herabstufung William Blair Outperform → Mkt Perform
2023-01-31 Eingeleitet Lake Street Buy
2022-07-18 Eingeleitet Craig Hallum Buy
2021-07-26 Eingeleitet Canaccord Genuity Buy
2021-07-26 Eingeleitet Piper Sandler Overweight
2021-07-26 Eingeleitet William Blair Outperform
Alle ansehen

Cvrx Inc Aktie (CVRX) Neueste Nachrichten

pulisher
Nov 27, 2024

CVRx Insiders May Regret Not Buying More, Market Cap Hits US$377m - Simply Wall St

Nov 27, 2024
pulisher
Nov 26, 2024

Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team - MSN

Nov 26, 2024
pulisher
Nov 22, 2024

(CVRX) Trading Report - Stock Traders Daily

Nov 22, 2024
pulisher
Nov 21, 2024

Paul Verrastro Sells 1,430 Shares of CVRx, Inc. (NASDAQ:CVRX) Stock - MarketBeat

Nov 21, 2024
pulisher
Nov 21, 2024

CVRx chief marketing officer Paul Verrastro sells $19,416 in stock By Investing.com - Investing.com Nigeria

Nov 21, 2024
pulisher
Nov 21, 2024

CVRx chief marketing officer Paul Verrastro sells $19,416 in stock - Investing.com

Nov 21, 2024
pulisher
Nov 21, 2024

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 21, 2024
pulisher
Nov 20, 2024

CVRx to Present at Piper Sandler 36th Annual Healthcare Conference in December | CVRX Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 17, 2024

CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Nov 17, 2024
pulisher
Nov 13, 2024

CVRx’s Barostim Gains New CPT Codes - MPO-mag

Nov 13, 2024
pulisher
Nov 13, 2024

CVRx Inc (CVRX) Shares Down 6.46% on Nov 13 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 11, 2024

(CVRX) Long Term Investment Analysis - Stock Traders Daily

Nov 11, 2024
pulisher
Nov 07, 2024

International Assets Investment Management LLC Makes New Investment in CVRx, Inc. (NASDAQ:CVRX) - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

CVRx: Impressive Top-Line Growth Seems Priced In - Seeking Alpha

Nov 06, 2024
pulisher
Nov 05, 2024

Cantor Fitzgerald Initiates Coverage of CVRx (CVRX) with Overweight Recommendation - MSN

Nov 05, 2024
pulisher
Nov 04, 2024

CVRx (NASDAQ:CVRX) Stock Price Expected to Rise, Craig Hallum Analyst Says - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

CVRx earns Medicare win for Barostim procedure - Mass Device

Nov 04, 2024
pulisher
Nov 04, 2024

CVRx gains CMS payment classification for Barostim - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025 - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

CVRx, Inc. (NASDAQ:CVRX) Position Decreased by Emerald Advisers LLC - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

CVRx, Inc. (NASDAQ:CVRX) Q3 2024 Earnings Call Transcript - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

FY2024 EPS Estimates for CVRx Lowered by Cantor Fitzgerald - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 01, 2024
pulisher
Oct 31, 2024

How the (CVRX) price action is used to our Advantage - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 31, 2024

CVRx Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Oct 31, 2024
pulisher
Oct 30, 2024

Canaccord lifts CVRx stock target, keeps buy rating on strong Q3 results By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Canaccord lifts CVRx stock target, keeps buy rating on strong Q3 results - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Earnings call: CVRx reports robust Q3 growth, eyes future reimbursement wins - Investing.com India

Oct 30, 2024
pulisher
Oct 30, 2024

CVRx (NASDAQ:CVRX) Given New $15.00 Price Target at Lake Street Capital - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

CVRx (NASDAQ:CVRX) Given "Overweight" Rating at Piper Sandler - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

CVRx Reports Strong Revenue Growth in Q3 2024 - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

CVRx earnings missed by $0.10, revenue topped estimates - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

CVRx: Q3 Earnings Snapshot - The Advocate

Oct 30, 2024
pulisher
Oct 29, 2024

CVRx Reports Third Quarter 2024 Financial and Operating Results - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

CVRx Inc Q3 2024 Earnings: Revenue Hits $13.4M, EPS at -$0.57, S - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

CVRx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 28, 2024

Earnings To Watch: CVRx Inc (CVRX) Reports Q3 2024 Result - GuruFocus.com

Oct 28, 2024
pulisher
Oct 26, 2024

CVRx (CVRX) Price Target Increased by 10.54% to 33.15 - MSN

Oct 26, 2024
pulisher
Oct 24, 2024

CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles - Investing.com India

Oct 24, 2024
pulisher
Oct 23, 2024

CVRx (NASDAQ:CVRX) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat

Oct 23, 2024

Finanzdaten der Cvrx Inc-Aktie (CVRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Cvrx Inc-Aktie (CVRX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
VERRASTRO PAUL
CHIEF MKTG & STRAT OFFICER
Nov 19 '24
Sale
13.58
1,430
19,417
1,875
medical_devices STE
$217.47
price up icon 0.65%
medical_devices ZBH
$112.02
price up icon 1.25%
medical_devices PHG
$27.15
price up icon 0.89%
$78.10
price up icon 0.21%
$83.00
price up icon 0.59%
medical_devices EW
$72.07
price up icon 0.73%
Kapitalisierung:     |  Volumen (24h):